Mesenchymal Stem Cells Cultured in 3D System Inhibit Non-Small Cell Lung Cancer Cells through p38 MAPK and CXCR4/AKT Pathways by IL-24 Regulating

被引：0
|
作者：
Suo, F. [1 ]
Pan, M. [1 ]
Li, Y. [1 ]
Yan, Q. [1 ]
Hu, H. [1 ]
Hou, L. [1 ]
机构：
[1] Beijing Jiaotong Univ, Coll Life Sci & Bioengn, Beijing 100044, Peoples R China
来源：
MOLECULAR BIOLOGY | 2021年 / 55卷 / 04期
基金：
中国国家自然科学基金;
关键词：
mesenchymal stem cells; three-dimensional cell culture; interleukin-24; tumor inhibition; NSCLC; MECHANISM; MICROENVIRONMENT; PROLIFERATION; SENSITIVITY; APOPTOSIS; HYDROGELS; PROMOTE; MODEL;
D O I：
10.1134/S0026893321030110
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Non-small cell lung cancer (NSCLC) is prevalent worldwide and has a high mortality rate. Even if mesenchymal stem cells (MSCs) are suggested as cancer treatment, the studies of their effects on NSCLC cells contradict each other, mainly due to utilization of two-dimensional (2D) culture system. Three-dimensional (3D) culture systems resemble tissue organization in vivo. Here we comprehensively explore the inhibitory effects of MSCs on NSCLC cells in a 3D culture system. We confirmed that the inhibitory effects of 3D-cultured MSCs (3D-MSCs) on the proliferation and migration of NSCLC cells are greater than that of the 2D-cultured MSCs. The expression of IL-24 in 3D-MSCs is higher than 2D-MSCs, which is the key factor to enhance the anti-tumor effect of MSCs. In these cells, IL-24 affects p38 MAPK and CXCR4/AKT pathways. Overall, this study provides the support for use of MSCs in tumor therapy.
引用
收藏
页码：589 / 603
页数：15
相关论文
共 50 条
  • [31] Bone Marrow Mesenchymal Stem Cells (BMSCs)-Originated miR-1298 Impedes the Aggressiveness of Non-Small Cell Lung Cancer by Hindering the Chemokine Receptor 4 (CXCR4)-Induced Epithelial-Mesenchymal Transition (EMT) Process
    Nie, Guangjie
    Wei, Xiaoqun
    Ye, Jun
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2022, 12 (06) : 1194 - 1201
  • [32] Correction to: Physalin A induces G2/M phase cell cycle arrest in human non-small cell lung cancer cells: involvement of the p38 MAPK/ROS pathway
    Ning Kang
    Jun-feng Jian
    Shi-jie Cao
    Qiang Zhang
    Yi-wei Mao
    Yi-yuan Huang
    Yan-fei Peng
    Feng Qiu
    Xiu-mei Gao
    Molecular and Cellular Biochemistry, 2022, 477 : 331 - 332
  • [33] Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: Role in non-small cell lung cancer tumor proliferation
    Wald, Ori
    Izhar, Uzi
    Amir, Gail
    Kirshberg, Sophie
    Shlomai, Zippora
    Zamir, Gideon
    Peled, Amnon
    Shapira, Oz M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2011, 141 (06): : 1503 - 1512
  • [34] β-elemene suppresses tumor metabolism and stem cell-like properties of non-small cell lung cancer cells by regulating PI3K/AKT/mTOR signaling
    Cheng, Guangyu
    Li, Lin
    Li, Qingjie
    Lian, Shulin
    Chu, Hongbo
    Ding, Yunlu
    Li, Chikun
    Leng, Yan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (04): : 1535 - 1555
  • [35] P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways
    Xue Bai
    Qianqian Li
    Xiaoxiang Peng
    Xinyu Li
    Cuicui Qiao
    Yiqing Tang
    Ronglan Zhao
    Purinergic Signalling, 2023, 19 : 685 - 697
  • [36] P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways
    Bai, Xue
    Li, Qianqian
    Peng, Xiaoxiang
    Li, Xinyu
    Qiao, Cuicui
    Tang, Yiqing
    Zhao, Ronglan
    PURINERGIC SIGNALLING, 2023, 19 (04) : 685 - 697
  • [37] Orai3-Mediates Cisplatin-Resistance in Non-Small Cell Lung Cancer Cells by Enriching Cancer Stem Cell Population through PI3K/AKT Pathway
    Abou Daya, Hiba
    Kouba, Sana
    Ouled-Haddou, Hakim
    Benzerdjeb, Nazim
    Telliez, Marie-Sophie
    Dayen, Charles
    Sevestre, Henri
    Garcon, Loic
    Hague, Frederic
    Ouadid-Ahidouch, Halima
    CANCERS, 2021, 13 (10)
  • [38] Long non-coding RNA SDPR-AS affects the development of non-small cell lung cancer by regulating SDPR through p38 MAPK/ERK signals (Expression of Concern of Vol 47, Pg 3172, 2019)
    Zhu, Junfei
    Wang, Lili
    Liao, Ruomin
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2022, 50 (01) : 222 - 222
  • [39] miR-519d-3p Overexpression Inhibits P38 and PI3K/AKT Pathway via Targeting VEGFA to Attenuate the Malignant Biological Behavior of Non-Small Cell Lung Cancer
    Zhang, Guangzhao
    Hu, Yanlei
    Yuan, Wuying
    Qiu, Hongli
    Yu, Haifeng
    Du, Jiahui
    ONCOTARGETS AND THERAPY, 2020, 13 : 10257 - 10266
  • [40] Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-jun NH2-terminal kinase pathways:: An effective therapeutic strategy for lung cancer
    Lee, HY
    Oh, SH
    Suh, YA
    Baek, JH
    Papadimitrakopoulou, V
    Huang, SY
    Kong, WK
    CLINICAL CANCER RESEARCH, 2005, 11 (16) : 6065 - 6074
12345